Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$10.61 USD
-0.13 (-1.21%)
Updated Nov 29, 2023 04:00 PM ET
Pre-Market: $10.75 +0.14 (1.32%) 8:32 AM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Earnings News For EDIT
-
Editas (EDIT) Q3 Earnings & Revenues Beat, Pipeline in Focus
-
Editas Medicine (EDIT) Reports Q3 Loss, Tops Revenue Estimates
-
Editas: Q3 Earnings Snapshot
-
Why Is Editas (EDIT) Down 4.3% Since Last Earnings Report?
-
Editas' (EDIT) Q2 Earnings Beat, Sales Miss, Pipeline in Focus
-
Editas Medicine (EDIT) Reports Q2 Loss, Misses Revenue Estimates
-
Editas: Q2 Earnings Snapshot
-
Editas (EDIT) Q1 Earnings Top, Pipeline in Focus, Stock Up
-
Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates
-
Editas: Q1 Earnings Snapshot
-
Earnings Preview: Editas Medicine (EDIT) Q1 Earnings Expected to Decline
-
Why Is Editas (EDIT) Down 21% Since Last Earnings Report?
-
Editas (EDIT) Q4 Earnings Miss Estimates, Pipeline in Focus
-
Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
-
Editas: Q4 Earnings Snapshot
-
Editas (EDIT) Down 13.8% Since Last Earnings Report: Can It Rebound?
-
Editas' (EDIT) Q3 Earnings Beat Estimates, Pipeline in Focus
-
Editas Medicine (EDIT) Reports Q3 Loss, Misses Revenue Estimates
-
Editas: Q3 Earnings Snapshot
-
Why Is Editas (EDIT) Down 19.5% Since Last Earnings Report?
-
Editas' (EDIT) Loss Narrows in Q2, Revenues Trump Estimates
-
Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates
-
Editas: Q2 Earnings Snapshot
-
Editas (EDIT) Down 20.7% Since Last Earnings Report: Can It Rebound?
-
Editas' (EDIT) Q1 Loss Narrows, Revenues Beat Estimates